Eleven Therapeutics
Latest round
- Seed
Last raised
- Aug 2022
Total raised
- $22M
Investors
- 6
About Eleven Therapeutics
Based in Tel Aviv, Israel, and founded in 2020, by Prof. Yaniv Erlich, Shaul Ilan, and Prof., aka Eleven Therapeutics, operates as a biotechnology company that primarily offers a combination of chemistry and artificial intelligence (AI) for RNA interference (RNAi) drug development. In August 2022, Eleven Therapeutics Ltd. Eleven Therapeutics offers SCSI-RNA, a programmable molecule used for analyzing diseases or biological targets of interest, as well as generating functional data about the activity profile of an unprecedented scale of siRNA (small interfering RNAs) molecules. The company also offers TERÅ beads (topologically encoded, RNA-active) platform to boost the performance of oligonucleotide therapeutics by creating DNA barcodes on each bead that record the pattern of these RNA modifications and make them available to high throughput sequencing.
Who invested in Eleven Therapeutics
6 investors across 1 round
See all investors in Eleven Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Aug 2, 2022
Amount
$22M
Investors
Questions about Eleven Therapeutics
Who invested in Eleven Therapeutics?
Eleven Therapeutics has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Eleven Therapeutics raised?
Eleven Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Eleven Therapeutics last raise money?
Eleven Therapeutics's most recent round on record is a Seed, in Aug 2022.
What does Eleven Therapeutics do?
Based in Tel Aviv, Israel, and founded in 2020, by Prof.
Where is Eleven Therapeutics headquartered?
Eleven Therapeutics is headquartered in Tel Aviv, Israel.
Which VCs invest in companies like Eleven Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Eleven Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Eleven Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.